| Names | |
|---|---|
| Preferred IUPAC name | 1,3-Bis(hydroxymethyl)imidazolidine-2,4-dione |
| Other names | Germall 115 Imidazolidine urea N-(1,3-Bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl) urea |
| Pronunciation | /ɪˌmɪdəˈzoʊlɪdənɪl ˈjʊəriə/ |
| Identifiers | |
| CAS Number | 39236-46-9 |
| Beilstein Reference | 3582093 |
| ChEBI | CHEBI:61022 |
| ChEMBL | CHEMBL3981606 |
| ChemSpider | 5320 |
| DrugBank | DB11191 |
| ECHA InfoCard | ECHA InfoCard: 03d0cf7742 |
| EC Number | EC 253-048-1 |
| Gmelin Reference | Gmelin 108077 |
| KEGG | C11199 |
| MeSH | D016326 |
| PubChem CID | 37131 |
| RTECS number | BU3150000 |
| UNII | 6W8XMU4MUA |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID7020636 |
| Properties | |
| Chemical formula | C11H16N8O8 |
| Molar mass | 388.46 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 0.5-0.6 g/cm3 |
| Solubility in water | Soluble in water |
| log P | 0.04 |
| Acidity (pKa) | 12.2 |
| Basicity (pKb) | 13.6 |
| Magnetic susceptibility (χ) | -7.2·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.593 |
| Viscosity | Viscous liquid |
| Dipole moment | 2.9907 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 643.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -792.8 kJ/mol |
| Pharmacology | |
| ATC code | D08AJ19 |
| Hazards | |
| Main hazards | May cause eye, skin, and respiratory irritation. May cause allergic skin reactions. |
| GHS labelling | GHS07, Warning, H317 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H317: May cause an allergic skin reaction. |
| NFPA 704 (fire diamond) | Imidazolidinyl Urea: "1-0-0 |
| Autoignition temperature | 438°C |
| Lethal dose or concentration | LD50 Oral Rat 11 g/kg |
| LD50 (median dose) | LD50 (oral, rat): 11,300 mg/kg |
| NIOSH | RN 39236 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.3-0.6% |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds | Diazolidinyl urea Formaldehyde Allantoin DMDM hydantoin Bronopol Quaternium-15 Methenamine |
| Property | Technical Commentary |
|---|---|
| Product Name | Imidazolidinyl Urea, a formaldehyde-releasing preservative, is primarily manufactured for personal care, pharmaceutical, and certain industrial applications that require microbial stability in water-based formulations. |
| IUPAC Name | N,N'-Methylenebis[N'-[1-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]. This name reflects the core condensation chemistry between urea and formaldehyde sources. |
| Chemical Formula | C11H16N8O8. Actual composition in bulk production reflects water content and resinous by-products; grade-specific formulation adjustments are made to fit regulatory and downstream use requirements. |
| Synonyms & Trade Names | Commercial lots are identified as Imidazolidinyl Urea, Germall 115, and by several proprietary trade labels depending on customer and distributor. Actual trade name may affect registration and documentation needs in specific regions, especially for cosmetic or pharmaceutical end users. |
| HS Code & Customs Classification | HS Code 292421 – Ureines and their derivatives; salts thereof. Customs classification for Imidazolidinyl Urea typically falls under this tariff item, but final classification may shift according to formulation, grade, or the intended import country’s regulatory protocols. Importers often request harmonized documentation that matches local interpretation for customs clearance and registration. |
Imidazolidinyl Urea arises from condensed urea and formaldehyde through controlled process steps that must be validated for residual formaldehyde, impurity species, and release profile per batch. Selection of urea grade, purity of input formaldehyde, and integrity of water supply define both the output’s regulatory compliance and its processing stability. Industrially, plant teams focus on minimizing batch-to-batch variation, targeting low free-formaldehyde content while maintaining antimicrobial effectiveness within permitted thresholds. Any adjustment in process—feedstock concentration, reaction temperature, or endpoint pH—impacts not only impurity spectrum but also the downstream solubility in formulations used by the customer. When manufacturing for sensitive cosmetics, tighter specifications for heavy metals, microbiological counts, and formaldehyde-releasing kinetics are imposed, with analytical release tied to validated in-process and post-blend testing.
In our production facilities, imidazolidinyl urea is produced as a white to off-white crystalline powder. Consistency in appearance is used as a preliminary quality check during batch release. Commercial batches may display minor variations in hue based on raw material purity and drying conditions. Odor is rarely pronounced, and off-odors indicating decomposition or contamination prompt a full internal review. Melting and decomposition typically occur well above room temperature, but observed ranges during quality assessment can be grade-sensitive. Direct boiling is not practically observed due to decomposition precedence.
Bulk density varies with granule size distribution, which is controlled by final milling and drying. Exact values are not standardized across all grades; customer process compatibility and dissolution performance often define optimal ranges.
Under recommended storage conditions, imidazolidinyl urea maintains chemical integrity suitable for formulation requirements. Incompatibility arises in strongly acidic or basic solutions and in the presence of oxidizing agents. Residual moisture and excess heat are known to accelerate degradation, contributing to impurity build-up, notably formaldehyde release. Stability assessments are performed for each production batch to verify product remains within expected limits based on intended application and market specification.
Water solubility is a prerequisite for most cosmetic and personal care grades. For consistent solution preparation during formulation, dissolve the powder in ambient temperature water with moderate agitation. Deviations in solubility performance may relate to particle size or residual process impurities. Organic solvent resistance is typically not a point of concern in conventional downstream use.
Specifications for imidazolidinyl urea are not universal and must align with customer industry, region, and local authority requirements. Cosmetics and personal care applications prioritize purity and control of formaldehyde release. Industrial and technical grades may emphasize broader impurity limits, trade-off with pricing, or suitability for non-regulated applications.
| Property | Typical Cosmetic Grade | Technical/Industrial Grade |
|---|---|---|
| Appearance | White, free-flowing powder | White to off-white powder |
| Assay (active content) | Defined by customer spec | Defined by application |
| Free formaldehyde | Tight control, often customer-driven | Broader or as requested |
| Moisture | Controlled for shelf-life | Broader acceptance |
Main impurities include residual reactants, byproducts such as dimethylolurea, and free formaldehyde. Maximum permissible limits are set either by regulatory bodies or by customer order specification, especially for personal care. Source analysis and batch traceability help track impurity contributions to final product.
Routine analysis includes HPLC and GC to quantify formaldehyde and key impurities. Water content, pH of 10% solutions, and assay by titration or gravimetric analysis form part of regular QC. External accredited labs may be involved on customer request for regulatory compliance testing.
Production begins with urea and formaldehyde of defined purity and reactivity grades, sourced based on cost-performance ratio and region licensure. Incoming raw materials are tested for functional impurities that impact reaction efficiency and downstream specifications.
Aqueous-phase condensation of urea with formaldehyde under controlled temperature and pH produces the target compound. Manufacturers select synthesis route variants according to energy costs, impurity minimization, and waste reduction considerations. Catalysts and process aids, when used, are chosen for minimal carry-over in final product.
Continuous monitoring of temperature, pH, and reactant feed rates ensures batch consistency. Downstream, multi-stage filtration, controlled crystallization, washing, and vacuum drying remove excess formaldehyde and residuals. Deviations during reaction or purification risk off-spec impurities, directly impacting releasable grade.
Each lot is sampled per internal control plan that reflects target industry and geography. Key release criteria are appearance, active content, moisture, and impurity panels. Full traceability is retained for every batch, with customer-specific CoA available.
Imidazolidinyl urea is moderately reactive in the presence of acids and bases, releasing formaldehyde under certain conditions. Formulation stability must be checked under these extremes, especially during shelf-life estimation or compatibility studies.
The reactivity can be modulated by altering temperature, catalyst inclusion, or solvent selection, but typical manufacturing avoids harsh conditions to suppress unwanted side reactions. Safety and product purity drive reaction optimization over theoretical yield.
Chemical transformation generally aims at modifying release rate or generating new preservative agents, but most production facilities focus on end-use ready material for direct downstream formulation. Requested modifications for derivative synthesis are assessed on a custom basis.
Powder storage occurs in cool, dry warehouses, avoiding direct sunlight and sources of heat. Exposure to moisture or volatile acids and bases is restricted, as these can accelerate decomposition and elevate impurity levels. Ambient humidity and temperature excursions beyond validated limits raise the risk of caking and deterioration.
Bulk packaging often utilizes polyethylene or fiber drums with internal liners. Metal drum use is avoided to prevent potential reactivity or leaching.
Product shelf life is defined by application requirements and stability data; visible discoloration, clump formation, or off-odor indicate off-spec status, requiring stock clearance or reworking. Customers with critical shelf-life needs can request stability data to define rotation cycles.
Classification aligns with formaldehyde-releasing agents and may shift based on grade and formaldehyde profile. User countries dictate finalized labeling requirements.
Powder handling uses dust control and avoidance of inhalation or direct contact. Waste must be managed to prevent environmental release of active substance and formaldehyde.
Toxicological concerns relate directly to formaldehyde content and release. For regulated applications, customers may request grade-specific toxicology summaries and support for regulatory filings.
Effective engineering controls and personal protective equipment are required in manufacturing and handling areas. The facility implements area monitoring and employee medical surveillance as suits site policy and regional regulations. Changes in occupational limits reflect global harmonization and regional enforcement.
Production scale for Imidazolidinyl Urea hinges on the availability and quality of raw materials, process throughput, and reactor uptime. Most production output is planned quarterly, with inventory levels tracked in real time by both process control and warehouse management. Capacity utilization shifts depending on downstream demand from personal care and preservation customers. In high purity or cosmetic grades, production is organized in campaign batches, with vigorous line cleaning and batch-to-batch segregation. Multi-grade plants may prioritize pharmaceutical or food-contact batches depending on order planning; this may temporarily reduce commercial availability for other sectors.
Standard manufacturing lead time typically reflects campaign changeover requirements, batch size optimization, and QA release windows. For most domestic shipments, lead time falls inside three to four weeks, but project orders, tailored grades, or large-volume exports may extend to eight weeks given logistics and documentation needs. Minimum order quantities vary with product grade and packaging format; bulk customers often contract full batch lots, while specialty buyers order smaller packaged units, subject to handling and packing process setup fees.
Packaging format is dictated by downstream formulation requirements, region-specific transport laws, and certification needs. Drum, fiber carton, and bagging options cover most freight requirements, with options for moisture barrier protection and tamper-evidence where prescribed. For regulated markets, tamper-proof and serialized packaging can be supplied on request, with clear batch labeling aligned with global traceability expectations. Certain grades may require inert gas blanketing or enhanced secondary containment to prevent caking or degradation under humid shipping conditions.
Freight corridor selection depends on customer risk tolerance, transit time sensitivity, and regulatory clearance requirements. Common terms include FCA, FOB, and CIP, with documentary compliance and insured carriage provided as standard for pharma, cosmetic, and food industry buyers. Payment structures reflect commercial credit terms, with long-standing partners offered deferred arrangements subject to risk assessment and history of order fulfillment cycles. For first-time or high-value shipments, advance or L/C payment frameworks remain common practice.
The primary cost drivers in Imidazolidinyl Urea manufacturing include urea derivatives, amine intermediates, and formaldehyde-based reactants. Variability in global urea and formaldehyde spot prices directly impacts monthly quotations. Feedstock pricing is influenced by petrochemical and natural gas markets, which undergo cyclic volatility traced to geopolitical events, plant outages, and environmental compliance shocks. Short-term cost spikes are often linked to abrupt energy supply constraints or raw material shipment bottlenecks—especially during hurricane or typhoon season, or in periods of unscheduled plant maintenance for upstream suppliers.
Grade determines the extent of purification, starting materials traceability, and testing panel required before release. Cosmetic and pharmaceutical grades command higher premiums, reflecting both regulatory testing and liability burden. Differences in process impurity profiles—mainly free formaldehyde and trace amines—mean only campaigns meeting the tightest limits can be certified for sensitive markets. Packaging compliance, such as food-contact approval or child-resistant locking, further escalates landed cost by adding material and certification overhead. Customers requiring serialization, anti-counterfeit seals, or region-specific marking may encounter step changes in final price.
Global demand traces population-driven growth in cosmetics, personal care, and preservative applications. North America and the EU purchase specialty and high-purity grades, tightly linked to aggressive regulatory enforcement and consumer preference for certified input materials. Asia, especially China and India, anchors high-capacity output with cost dominance in commodity and technical grades. Supply can tighten abruptly when downstream formulation rules shift or when major plants undergo planned overhaul. Balance between local producers and imports remains fluid due to shifting non-tariff barriers and regulatory shifts.
US and EU buyers demand full-chain traceability and comprehensive QC documentation, driving premium pricing and lengthier approval cycles. Japanese formulators prioritize ultra-low impurity profiles and closely monitored logistics chains. Indian and Chinese buyers typically leverage price competition for bulk and technical volumes, though regulatory convergence has started to erode the gap for higher-end grades. Freight surcharges and currency volatility introduce further price swings, especially for dollar- or euro-denominated supply contracts.
Industry-wide price movement depends most on feedstock stability, regulatory drift, and freight system robustness. With expected upstream energy volatility and incremental tightening in EU/US preservative regulations, specialty-grade costs likely rise in absolute terms, with technical grades more exposed to commodity market shocks. Margin compression may trigger further regional specialization, with Asia focusing on scale and Europe/US on compliant, traceable supply. Market analyst consensus currently projects annualized price growth ahead of CPI for certified grades through 2026, subject to raw material and regulatory shocks.
Supply and price outlooks draw on internal production histories, regional sales data, industry association reporting, third-party price benchmarks for urea and formaldehyde, and spot-traded logistics rates. Comparisons incorporate quarterly contract review cycles and ongoing feedback from key accounts across major geographies.
Some multinational formulators have moved to restructure sourcing strategies in response to preservative bans and NGO campaigns around formaldehyde donors. Major customers have requested reformulation projects aiming to reduce free formaldehyde release or transition to next-generation blends, which has accentuated grade differentiation and increased technical support workload for batch amendments.
Recent regulatory developments in the EU and North America have tightened scrutiny of formaldehyde donor preservatives. Threshold enforcement on residual formaldehyde and new requirements for traceability and contaminant screening have come into effect. Plant QA teams have responded by revising in-process controls and adopting batch-level documentation to support audits and rapid change management.
Production and quality control have focused on process route optimization, selective raw material vendor auditing, and increased impurity monitoring, especially for cosmetic and pharma grades. Customer service and technical support teams have stepped up collaboration with formulation chemists, providing analytical data packages and reformulation assistance to safeguard continuity of compliance and supply.
Imidazolidinyl Urea production supports distinct segments, each placing its own performance and purity demands:
| Grade | Primary Field | Critical Selection Factors |
|---|---|---|
| Cosmetic Grade | Personal Care | Conformance to international cosmetic ingredient standards; low impurity profile; clarity and color requirements; documented allergen risk assessment |
| Technical Grade | Household/Industrial | Process residue control; bulk dusting characteristics; cost-to-performance balance; functional tolerance for trace byproducts |
| Pharmaceutical Grade | Pharma/Regulated | Documented compliance with pharmacopeia (e.g., USP, EP); verified low formaldehyde and bioburden; dedicated production line separation; traceability |
Selection begins with a practical review of the final use environment—product type, exposure risks, compatibility with other actives, and typical shelf life demands. Define if the product enters a regulated supply chain or standard commodity market.
Cross-reference all expected market regulations. Cosmetics often require conformance with EU, US, and APAC ingredient lists and impurity tolerances, while pharma applications must match the specifications of national pharmacopeia or ICH documentation. Household and industrial grades see more variation, driven by downstream processing sensitivity or worker safety strategies.
Purity requirements directly reflect application and customer quality system maturity. Pharmacopeial and cosmetic end uses require full impurity profiling and release documentation, including batch-specific data on potentially sensitizing byproducts. For less-sensitive large volume uses, key performance indicators may focus more on cost-effectiveness and blending ease than on trace residuals.
Volume projections combine with budget guidance to clarify which packaging format, batch sizing, and in-process handling options best suit the manufacturing setup. Large-volume detergent or industrial customers often accept technical grades if it reduces cost and meets established hurdles for process compatibility.
Sample requests enable customers to assess real-world compatibility and run laboratory or pilot scale tests. Direct performance validation in intended formulations—supported with technical from the QC and production team—verifies chemical functionality and screens for possible handling or stability issues. Manufacturer technical support responds best to data-driven customer feedback from this stage.
Manufacturing Imidazolidinyl Urea for industrial and formulation supply markets means operating under documented quality systems. Our production is managed in compliance with recognized quality management frameworks, which guide batch recordkeeping, deviation management, and continuous improvement. System effectiveness is measured by internal audit findings, non-conformance closure rates, and the ability to support unannounced inspections from customer auditors. Alignment with international quality management standards extends to all critical process steps—from raw material qualification, in-process testing, to traceability protocols for finished material release. Specific certificate versions differ by production site and customer sector, as requirements for cosmetics differ from those applied in industrial biocides.
Compliance verification targets applications subject to sector regulations. For Imidazolidinyl Urea supplied into regulated segments like cosmetics, certificate provision includes statements on allergen management, traceability to feedstock, and conformity declarations to standards such as ISO or region-specific regulations. The need for batch-specific analytical data, microbiological testing, and absence of prohibited substances is confirmed by detailed certificates of analysis. Where required by downstream users, release documentation features third-party validation of microbial and purity levels, but actual acceptance limits follow customer and market specifications. The certification portfolio adapts to changing regulatory and end-use demands, with updates triggered by new legislative frameworks or customer audits.
Full traceability is built into batch manufacturing documentation: each batch is traceable to raw material lots, production campaigns, and all associated in-process control data. Batch certificates, technical data sheets, and safety documentation are maintained in electronic and retrievable form for the full internal retention period. Reports on specification compliance, finished goods analysis, and process deviations are available for supported grades. Upon request, supply can include change notification statements, impurity profiling (where critical), and process validation summaries relevant to the delivered batch or grade.
Plant capacity planning in Imidazolidinyl Urea production reflects demand forecasts, feedstock market volatility, and scheduled maintenance requirements. Output stability is prioritized through redundancy in process lines and careful management of intermediate stocks. Customer volume requirements—spot or contract—shape the cooperation model: some partners request regular forecast-driven deliveries, others call for agile order cycles or inventory holding arrangements. Supply assurance relies on both upstream raw material qualification and downstream capacity reservation, with capability to commit to high-volume annual agreements or flexible, as-needed replenishment.
The heart of consistent Imidazolidinyl Urea supply lies in controlling upstream material flows and process bottlenecks. Core reactor and purification unit throughput determines both batch size and campaign scheduling flexibility. Possible supply constraints arise from specialty feedstock lead times, seasonal demand swings, or statutory regulatory changes affecting run rates. Buffer stock policies and dual-sourcing options mitigate these risks where feasible. Routine production campaigns address contracted partners, while emergency production slots handle urgent, validated customer needs as plant scheduling permits.
Sample provision matches the grade or format requested by technical buyers or formulation scientists. Requests trigger internal sample batch registration, documentation preparation (including up-to-date CoA and safety data), and packing under controlled, contamination-minimizing conditions. Application approval depends on regulatory classification of the destination—certain sample shipments to sensitive end uses require extra documentation or pre-approval from regulatory or safety authorities. Lead times and logistics options differ for regional and international clients, and are communicated at sample request acknowledgment.
Collaboration models center on aligning supply schedules, documentation needs, and order management systems. Flexibility extends to consignment stock, split-shipment protocols, and synchronized documentation handover for multi-location partners. For technical or regulatory-driven projects, joint development batches and pilot production runs can be coordinated against project gates or milestones. Minimum order quantities, packaging types, and delivery terms are negotiated according to buyer storage capacities and forecast accuracy. Ongoing feedback from procurement and R&D partners informs further refinement of flexibility protocols, ensuring operational alignment without compromising on critical compliance or quality demands.
Researchers focus on the impact of raw material selection and reaction control on the microbiological stability profile of imidazolidinyl urea. Formulators actively investigate preservative blend compatibilities, especially in rinse-off and leave-on cosmetic systems. There is ongoing work on purity profiling, concentrating on secondary amine contents and formaldehyde release rates by batch and process variant. Differences in impurity fingerprint and decomposition products drive new analytical method development, mainly HPLC and GC techniques, to assist quality assurance and regulatory compliance in high-spec markets.
Demand for low-formaldehyde and formaldehyde-free systems is increasing in personal care, and this directly influences our R&D direction. Industrial users are exploring imidazolidinyl urea blends with phenoxyethanol or other non-paraben partners to address cross-compatibility, pH range extension, and broad-spectrum preservation. There is expanded application review for water-based adhesives and emulsion polymer dispersions, requiring attention to compatibility with acrylate, polyurethane, and PVA systems.
Consistent batch-to-batch release of low-residual free formaldehyde presents a core technical hurdle, particularly when working under variable reaction temperature or with recycled ammonia feedstocks. R&D teams have improved purification sequence control, employing additional stripping and crystallization cycles to narrow final product variability. Adapting test method sensitivity to distinguish trace formaldehyde in complex matrices remains a shared challenge within the industry. Advances in controlled-release formulations and encapsulation during synthesis are being piloted to enhance shelf stability and performance in sensitive applications.
Market growth is tied to continued international movement toward allergen and irritant minimization in personal care formulations, as well as regulatory pressures in Europe, North America, and East Asia. Some legacy markets are anticipated to contract as new preservative systems penetrate. Where imidazolidinyl urea maintains usage, demand will focus on high-purity, certified-lot supply, with added emphasis on traceability and contaminant transparency. Multi-site producers with robust quality control systems are positioned to meet evolving market expectations.
Process improvements emphasize precise pH control and in situ monitoring of the methylolation stage, reducing variability across process scales. Manufacturers are leveraging automation and process analytical technology (PAT) to detect deviations earlier and adjust parameters dynamically. There is measurable interest in closed-loop purification systems to lower secondary contamination risk and meet stricter regulatory audit demands. Ongoing technical collaboration with downstream users helps optimize product consistency for unique formulation environments found in cosmetics, coatings, and adhesives.
Supply chains are prioritizing reduced generation of formaldehyde-containing wastewater and solvent recovery for circular process flows. Green chemistry principles drive procurement of urea and glycine streams with documented lower environmental footprint, and process engineers are piloting transition to renewable-based ammonia where feasible. Sustainability efforts include investments in continuous versus batch reactor designs to maximize energy efficiency and minimize off-gas. Product stewardship now includes extended producer responsibility, with technical data sharing on end-of-life fate for customers pursuing eco-labels and safer product certifications.
Process and support engineers routinely engage in detailed technical consultation, tailored to customer batch history and formulation targets. Guidance covers analytical troubleshooting, impurity traceability, and process compatibility, with specific recommendations given only after reviewing customer-provided formulation matrices and process flow data. Qualification protocols for each batch can be adjusted to meet region-specific regulatory documentation or “cleanroom” end-use needs.
Technical teams collaborate with customers to refine preservative loading, optimize dosing points, and track the impact of product grade selection across varying pH, temperature, and ingredient systems. For high-value applications, we assist with bench- and pilot-scale protocol adaptation to mitigate unexpected interaction or degradation during downstream processing. Application support extends to shelf-life simulation and accelerated aging studies, using customer-specific formulation matrices.
Every delivery batch includes a certificate outlining product identity, lot-level analytical data, and actual measured values for relevant impurities. If downstream process changes or non-conformance episodes occur, root cause analysis is implemented by both technical and quality assurance representatives, offering corrective guidance and, where appropriate, batch recall participation. Feedback from customers feeds directly into process refinement and ongoing QA document updates, with customer service assigning a technical contact point for any incident or query related to imidazolidinyl urea supply.
As a producer of industrial-grade Imidazolidinyl Urea, our manufacturing operation focuses on rigorous batch production, in-house process control, and raw material traceability. From urea and glyoxal to end-product, all stages run under plant-level oversight with regular validation to avoid drift in chemical composition. Continuous monitoring ensures lot-to-lot reproducibility and helps maintain the microbiological purity expected by formulation chemists in personal care and industrial preservative sectors.
Imidazolidinyl Urea remains a mainstay in personal care, household, and coatings sectors as a trusted antimicrobial preserving agent. In handwash liquids, creams, and surface cleaners, this preservative delivers steady protection against a broad spectrum of bacteria and yeast. Paint and adhesive producers integrate it for its reliable release of formaldehyde under controlled conditions, matching the preservation lifespans required by manufacturers supplying major downstream brands.
Process engineers and plant chemists manage daily production with focus on analytical feedback loops. Spectroscopic checks, titration, and purity testing for each batch ensure active content stays within narrow specifications demanded by leading multinational customers. Sampling follows standard operating procedures at defined intervals with documented inspection histories accessible for customer audits. Our production never relies on batch blending—each shipment ties back to a discrete, verified lot.
Industrial clients expect supply chain dependability and straightforward logistics. Our facilities fill and seal Imidazolidinyl Urea in multiple formats, including fiber drums, PE-lined bags, and customizable super sacks for automated dispensing systems. Packing lines run inside controlled, dust-free spaces. All packaging options meet strict requirements for safe bulk transport within Asia, North America, and Europe, supporting recurring contracts and continuous line feeding for major manufacturing plants.
Product managers, formulation scientists, and plant procurement teams often seek operational clarity on preservative selection, solubility, and compatibility. Our technical team shares direct production insights, supporting industrial integrators with hands-on recommendations for dilution schemes, method development, and compliance with changing preservative regulations. Response teams resolve queries for formulation troubleshooting and can reference laboratory data based on real batch samples, not generic brochures.
Our clients—large-scale manufacturers, multinational distributors, and institutional procurement groups—place value on process reliability and documentation. Process control, material trace, and batch certification translate into predictable end-product function and lower risk of recall or technical rejection. For buyers managing compliance, traceability at every step simplifies regulatory reporting. Inventory programs, secured capacity, and primary producer pricing models reinforce the commercial feasibility of downstream production.
As a manufacturer with decades dedicated to cosmetic preservatives, the topic of Imidazolidinyl Urea concentration comes up with nearly every formulation project we handle. It is one of those questions that carries both regulatory guardrails and practical, hands-on experience. Anyone producing skin care, hair care, or personal hygiene products wants preservative action without compromising the finished product's stability or skin feel. We have spent years optimizing our processes to help formulators balance that line.
In our own production support and guidance work, concentrations for Imidazolidinyl Urea in cosmetics generally fall between 0.3% and 0.6%. There is a good reason this range appears time and again—not just in regulatory documents, but in batch records from hundreds of customers across the globe. Preservative efficacy at these levels has been extensively validated both in lab-scale challenge tests and through real-world shelf life. Go below 0.3% and the spectrum of protection for bacteria or fungus can drop off, especially in high water activity formulations. Move above 0.6% and the risk of skin irritation, particularly with repeated use products, goes up. This is not just regulatory caution—it’s been demonstrated in patch test studies and consumer feedback loops our development chemists track.
We always recommend considering the full system when setting your target concentration. Heavy plant extract loads, anionic surfactants, or challenging pH levels require careful evaluation. Our technical team sees that adding Imidazolidinyl Urea at 0.4% can give robust protection in well-designed emulsions. Clear gels or high-protein blends might push closer to 0.5% for safety margins. We have worked with large and small brands alike who have tried to reduce preservative concentrations only to realize microbial stability cannot be compromised without risking consumer safety or triggering costly recalls. These lessons shape our application guides and customer support today.
EU Cosmetic Regulation and US FDA guidelines advise 0.6% as an upper limit, and our batches never exceed this marker. In some Southeast Asian markets, authorities review in-market products for compliance, especially regarding preservatives. Our compliance specialists monitor such regulatory trends and update technical documents for partners. Each customer batch is supported with detailed lab analysis and test results—these are not generic claims, but backed by specific lot numbers and traceable QC records.
Stability and safety remain front and center. To achieve this, we maintain high purity standards for our Imidazolidinyl Urea with precise control over residual formaldehyde, using state-of-the-art reaction and purification technology. Our QC team runs challenge testing as part of every process batch, not as an afterthought but as a guarantee. If your cosmetic formulation contains botanicals, proteins, or anything out of the mainstream, we offer technical consultation to help fine-tune the preservative level, ensuring protection while maintaining product aesthetics and regulatory compliance. Detailed usage recommendations and support for preservative efficacy testing are available directly from our technical department to address application-specific questions.
Choosing the right concentration for Imidazolidinyl Urea never happens in isolation. The numbers are more than just data points—they reflect thousands of lab validations and direct market experience. We make sure every batch leaving our facility stands up to these expectations, allowing partners to build safer, more reliable cosmetic products.
Sourcing Imidazolidinyl Urea in large quantities brings unique requirements. Many of our customers rely on secure, consistent supply streams from the original manufacturing site. In our experience, clarity around order minimums and packaging is one of the most practical starting points when it comes to streamlining procurement for both established and emerging production lines.
As a chemical manufacturer, volume drives efficiency and quality control. Our production line is designed for industrial output and tailored for partners using Imidazolidinyl Urea across large-scale cosmetic, personal care, household, and technical formulations. The minimum order quantity for bulk shipment is set at one full pallet, which equates to 200 kilograms. This level of output reduces the risk of cross-contamination, supports rigorous batch traceability measures, and helps maintain competitive price points by maximizing production consistency.
Our packaging team leverages years of experience in optimizing both safety and logistical efficiency. Standard packaging formats for Imidazolidinyl Urea reflect the realities of bulk processing and downstream handling. The product is filled into high-integrity fiber drums with double PE inners, each with a nominal net weight of 25 kg. This drum specification strikes a proven balance, allowing for manageable individual handling while also delivering the volume needed for continuous production runs.
For higher-volume applications—such as contract manufacturing or central warehouse storage—we provide 500 kg jumbo bags. These are constructed with antistatic liners and reinforced seams, keeping moisture and contaminants out during storage or transport. Secure stacking and quick unloading with forklifts support efficient transfer onto production lines or further blending operations.
Over the years, we have observed that customers managing global brands value standardized packaging. It minimizes disruptions, eliminates surprises at receiving docks, and keeps inventories aligned during high-throughput seasonal runs. Palletized drums or flexible intermediate bulk containers both enable better space utilization inside shipping containers, reducing the risk for damage or product waste.
In some instances, clients require modifications related to pallet configuration, barcode labeling, or even humidity indicators placed within the packaging. Our production and packaging systems accommodate these adjustments after in-depth discussion with technical staff or procurement leaders. For high-sensitivity applications, gamma-irradiated or pre-flushed packaging can be prepared in conjunction with strict GMP controls.
Recent years have seen increasing end-user attention on packaging recyclability and source certification. Our containers, both drums and bags, are made from materials accepted by major recycling chains. Batch documentation accompanies all bulk shipments to support audits and regulatory disclosure. Any changes in packaging, palletizing, or custom order size are coordinated directly by our in-house teams to maintain compliance with global transport regulations.
Direct communication between factory and finished product formulators leads to faster resolution of supply chain bottlenecks. We keep our bulk procurement terms transparent, balancing manufacturing constraints with the flexibility required by global sourcing teams. As demand for Imidazolidinyl Urea evolves, from classic preservation roles to newer formulations, we stand ready to review specific volume or packaging preferences in line with long-term production agreements.
Manufacturing imidazolidinyl urea means staying in step with ever-evolving global chemical regulations. REACH—Registration, Evaluation, Authorisation and Restriction of Chemicals—has set the standard across Europe for chemical safety and supply transparency. Our registration of imidazolidinyl urea with ECHA covers both volume requirements and ongoing obligations to monitor safety data. Each batch leaves our plant fully documented, traceable, and registered under REACH, so clients importing into the EEA will not face customs or regulatory hold-ups related to registration or data availability.
Our technical documentation includes up-to-date safety data sheets (SDS) in all major EU languages, compliant with Article 31 of REACH and aligned with the most recent CLP requirements. We routinely review hazard classification and PBT/vPvB status, ensuring our SDS reflects the most current findings. In practical terms, our clients can purchase with confidence, knowing that obligation for pre-registration, registration, and labeling has been met from raw material through finished product.
Imidazolidinyl urea, as we produce and sell it, does not meet the classification of a hazardous substance under the current CLP Regulation (EC No 1272/2008). This means that drums, sacks, and intermediate bulk containers depart from our facilities with clear, compliant labeling but without the array of hazard warnings and pictograms reserved for more critical chemicals. Our standard labels show the product trade name, chemical identity, weight, batch number, and manufacturer identification, fully aligned with GHS and local requirements for all primary export markets.
Our shipping documentation covers MSDS/SDS, commercial invoice, packing list, and Certificate of Analysis, matching the requirements for LCL, FCL, air, and land consignments. For international destinations outside Europe, we produce paperwork referencing both REACH compliance and destination regulatory standards. Experience tells us that some ports and transit routes implement their own requirements; our logistics team regularly liaises with carriers and customs brokers to pre-clear routes and paperwork, so delays rarely occur due to paperwork gaps.
By actively engaging with major international auditing and certification bodies, our facility maintains ISO quality and environmental management systems. This not only streamlines compliance for end users but pushes our documentation and labeling up to a higher international benchmark, reducing headaches for downstream partners. Our technical, regulatory, and export documentation is updated annually—or immediately in the event of significant regulatory change—so partners will not receive outdated paperwork.
Shipping imidazolidinyl urea globally brings its own set of challenges, especially under the tightening network of international chemicals regulation. We saw an uptick in requests for detailed impurity profiles and residual formaldehyde statements in key markets; our quality team provides transparent, batch-specific certificates for every shipment. Clients entering new regulatory environments, such as Southeast Asia or the Americas, can rely on our established documentation and technical support to accelerate customs clearance and prevent regulatory disputes.
REACH and similar regimes expect chemical manufacturers to look beyond product delivery and consider lifecycle safety and data transparency. Each round of REACH evaluation drives us to invest in new lab analytics, staff training, and documentation upgrades. For our clients, this translates to product supplied with minimized compliance risk—ensuring stability all the way from our manufacturing floor to their application line.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
